AnaBios pledges to conscientiously work to develop knowledge that will benefit the advancement of science and mankind through improved human-relevant drug development and drug safety programs. AnaBios firmly believes that all organ and tissue donations must be treated with the utmost respect and dignity, and understands the profound ethical and moral responsibility with respect to the donor families and their precious “gift of life” donations to help advance research.
AnaBios partners directly with key transplant centers in the US to facilitate the recovery of human tissue from fully consented organ donors. Each transplant center is governed by several accrediting agencies and is subject to one or more forms of US federal oversight including:
- Informed Consent
- Donor Screening
- Medical/Social History
- Medical Chart Review
- Physical Examination
- Infectious Disease Testing
In each case, informed consent is provided either via first person consent (driver’s license or other legally binding document) or from the donor’s legal next of kin. Consent procedures utilized meet the standard guidelines concerning informed consent for organ donation for research in a “for profit” environment as established by industry practice and governed by the Uniform Anatomical Gift Act. AnaBios only provides anonymous and/or de-identified patient information as defined in the Health Insurance Portability and Accountability Act (HIPAA).